Khaitan & Co acts on NATCO Pharma ₹1,279 crore rights issue

NATCO Pharma has made a rights issue of 17,058,082 fully paid-up equity shares.

Bar & Bench

Published:2nd Nov, 2026 at 11:06 AM

NATCO Pharma Limited has made a rights issue of 17,058,082 fully paid-up equity shares, aggregating to ₹1,279.4 crore.

Khaitan & Co advised NATCO Pharma on this rights issue.

The transaction team consisted of Thomas George (Partner), Nagashayana Srinivasaiah (Partner), Pooja Agarwal (Senior Associate), Tharun Vadlapatla (Senior Associate), Anand Sivasankaran (Associate) and Shishir Tripathi (Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Khaitan & Co acts on NATCO Pharma ₹1,279 crore rights issue

NATCO Pharma has made a rights issue of 17,058,082 fully paid-up equity shares.

Also Read

Kerala High Court Justice Bechu Kurian Thomas completes Ironman 70.3 triathlon in Goa

Allahabad High Court directs State to pay ₹1.25 lakh to man for 5-day illegal detention

Indian scientist secures patent for in-vivo power generator after Bombay High Court order against IIT

Courts reviewing arbitral award on merits defeats purposes of arbitration: Chief Justice Vibhu Bahkru

Bhushan Power: NCLT rejects promoters’ challenge to maintainability of government's recovery plea